Acromegaly with Fibrous Dysplasia: McCune-Albright Syndrome - Clinical Studies in 3 Cases and Brief Review of Literature

Endocrine Journal

Volumn 50, Issue 6, 2003, Pages 793-799

  Bhansali, Anil ^a   Sharma, Bhawani S ^a   Sreenivasulu, Polupoina ^a   Singh, Paramjit ^a   Vashisth, Rakesh K ^a   Dash, Radharaman J ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Acromegaly; Fibrous dysplasia; Somatotropinoma

Indexed keywords

FOLLITROPIN; GROWTH HORMONE; LEVOTHYROXINE; LUTEINIZING HORMONE; MEDRONATE TECHNETIUM TC 99M; PREDNISOLONE; PROLACTIN; PROTIRELIN; TESTOSTERONE;

ACROMEGALY; ADULT; ALBRIGHT SYNDROME; ARTICLE; BODY HEIGHT; BODY MASS; CAFE AU LAIT SPOT; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; ENDOCRINE DISEASE; FIBROUS DYSPLASIA; HUMAN; HYPOPHYSIS ADENOMA; MALE; PHYSICAL EXAMINATION;

ACROMEGALY; ADENOMA; ADULT; FIBROUS DYSPLASIA, MONOSTOTIC; FIBROUS DYSPLASIA, POLYOSTOTIC; HUMAN GROWTH HORMONE; HUMANS; MALE; PITUITARY NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0942276909     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.50.793     Document Type: Article

References (35)

1. McCune DJ (1936) Osteitis fibrosa cystica: the case of nine year old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child 52: 743-747.
2. Albright F, Butler AM, Hampton AO, Smith P (1937) Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females: reports of five cases. N Engl J Med 216: 727-746.
3. Chanson P, Dib A, Visot A, Derome PJ (1994) McCune-Albright syndrome and acromegaly: clinical studies and response to treatment in five cases. Eur J Endocrinol 131: 229-234.
4. Premawardhana LDKE, Vora JP, Mills R, Scanlon MF (1992) Acromegaly and its treatment in the McCune-Albright syndrome. Clin Endocrinol 36: 605-608.
5. Scurry MT, Bicknell JM, Fajans SS (1964) Polyostotic fibrous dysplasia and acromegaly. Arch Intern Med 114: 40-45.
6. Lightner ES, Penny R, Frasier SD (1975) Growth hormone excess and sexual precocity in polyostotic fibrous dysplasia (McCune-Albright syndrome): evidence for abnormal hypothalamic function. J Pediatr 87: 922-927.
7. Joishy SK, Morrow LB (1976) McCune-Albright syndrome associated with a functioning chromophobe adenoma. J Pediatr 89: 73-75.
8. Powell DGB (1976) Polyostotic fibrous dysplasia with acromegaly (Albright's syndrome). S Afr Med J 50: 182-183.
9. Carr D, Matthie IK, Manners AR, Colman C (1979) Hyperprolactinaemia in a patient with the McCune-Albright syndrome. Br J Obstet Gynaecol 86: 330-331.
10. Albin J, Wu R (1981) Abnormal hypothalamic-pituitary function in polyostotic fibrous dysplasia. Clin Endocrinol (Oxf) 14: 435-443.
11. Lipson A, Hsu TH (1981) The Albright syndrome associated with acromegaly: report of a case and review of the literature. Johns Hopkins Med J 149: 10-14.
12. Polychronakos C, Tsoukas G, Ducharme JR, Letarte J, Collu R (1982) Gigantism and hyperprolactinemia in polyostotic fibrous dysplasia (McCune-Albright syndrome). J Endocrinol Invest 5: 323-326.
13. Chung KF, Alaghband Zadeh J, Guz A (1983) Acromegaly and hyperprolactinemia in McCune-Albright syndrome. Am J Dis Child 137: 134-136.
14. Kovacs K, Horvath E, Thorner M, Rogol AD (1984) Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. Virchows Arch (Pathol Anat) 403: 77-86.
15. Nakagawa J, Nagasaka A, Sugiura T, Nakagawa K, Yabe Y, Nihei N, et al. (1985) Gigantism associated with McCune-Albright's syndrome. Horm Metab Res 17: 522-527.
16. Harris RI (1985) Polyostotic fibrous dysplasia with acromegaly. Am J Med 78: 539-542.
17. Mauras N, Blizzard RM (1986) The McCune-Albright syndrome. Acta Endocrinol (Copenh) Suppl 113: 207-217.
18. Present D, Bertoni F, Enneking WF (1986) Osteosarcoma of the mandible arising in fibrous dysplasia. Clin Orthop Relat Res 204: 238-244.
19. Geffner ME, Nagel RA, Dietrich RB, Kaplan SA (1987) Treatment of acromegaly with a somatostatin analog in a patient with McCune-Albright syndrome. J Pediatr 111: 740-743.
20. Misaki M, Shima T, Ikoma J, Morioka K, Suzuki S (1988) Acromegaly and hyperthyroidism associated with McCune-Albright syndrome. Horm Res 30: 26-29.
21. Cuttler L, Jackson JK, Uz-Zafar MS, Levitski LL, Mellinger RC, Frohman LA (1989) Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome. J Clin Endocrinol Metab 68: 1148-1154.
22. Pun KK, Chan G, Kung A, Lam K, Chan FL, Wang C (1989) McCune-Albright syndrome with acromegaly. Horm Metab Res 21: 527-528.
23. Mortensen A, Bojsen-Moller M, Rasmussen P (1989) Fibrous dysplasia of the skull with acromegaly and sarcomatous transformation. J Neuro-oncol 7: 25-29.
24. Huang TS, Chang CC, Huang JS, Hsieh HC, Chen FW (1990) Albright's syndrome with acromegaly and Hashimoto's thyroiditis: report of a case. J Formos Med Assoc 89: 714-718.
25. Abs R, Beckers A, Van de Vyver FL, De Schepper A, Stevenaert A, Hennen G (1990) Acromegaly, multinodular goiter and silent polyostotic fibrous dysplasia. A variant of the McCune-Albright syndrome. J Endocrinol Invest 13: 671-675.
26. Kupcha PC, Guile JT, Tassanawipas A, Bowen J (1991) Polyostotic fibrous dysplasia and acromegaly. J Pediatr Orthop 11: 95-99.
27. Sherman SI, Ladenson PW (1992) Octreotide therapy of growth hormone excess in the McCune-Albright syndrome. J Endocrinol Invest 15: 185-190.
28. Cremonini N, Graziano E, Chiarini V, Sforza A, Zampa GA (1992) Atypical McCune-Albright syndrome associated with growth hormone-prolactin secreting pituitary adenoma: natural history, long-term follow-up, and SMS 201-995-bromocriptine combined treatment results. J Clin Endocrinol Metab 75: 1166-1169.
29. Garcia MB, Koppeschaar HP, Lips CJ, Thijssen JH, Krenning EP (1994) Acromegaly and hyperprolactinemia in a patient with polyostotic fibrous dysplasia: dynamic endocrine studies and treatment with somatostatin anaglogue octreotide. J Endocrinol Invest 17: 59-65.
30. Gessl A, Freissmuth M, Czech T, Matula C, Hainfellner JA, Buchfelder M, Vierhapper H (1994) Growth hormone-prolactin-thyrotropin secreting pituitary adenoma in atypical McCune-Albright syndrome with functionally normal Gsα protein. J Clin Endocrinol Metab 79: 1128-1134.
31. Feuillan PP, Jones J, Ross JL (1995) Growth hormone hypersecretion in a girl with McCune-Albright syndrome: comparison with controls and response to a dose of long-acting somatostatin analog. J Clin Endocrinol Metab 80: 1357-1360.
32. Ihara C, Shimatsu A, Murabe H, Kataoka K, Kondo C, Nakao K (1996) Growth hormone secreting pituitary adenoma associated with multiple bone cysts, skin pigmentation and aortitis syndrome. J Endocrinol Invest 19: 753-757.
33. Obuobie K, Mullik V, Jones C, John R, Rees AE, Davies JS, Scanlon MF, Lazarus JH (2001) McCune-Albright syndrome: Growth hormone dynamics in pregnancy. J Clin Endocrinol Metab 86: 2456-2458.
34. Akintoye SO, Chebli C, Booher S, Feuillan P, Kushner H, Leroith D, Cherman N, Bianco P, Wientroub S, Robey PG, Collins MT (2002) Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. J Clin Endocrinol Metab 87: 5104-5112.
35. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM (1991) Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325: 1688-1695.